Section Arrow
RVMD.NASDAQ
- Revolution Medicines
Quotes are at least 15-min delayed:2026/03/06 16:26 EST
After Hours
Last
 98.69
-- (--)
Bid
98.37
Ask
98.41
High 98.69 
Low 98.4 
Volume 255.97K 
Regular Hours (Closed)
Last
 98.36
-1.31 (-1.31%)
Day High 
100.08 
Prev. Close
99.67 
1-M High
107.45 
Volume 
1.59M 
Bid
98.37
Ask
98.41
Day Low
97.31 
Open
98.17 
1-M Low
93.7901 
Market Cap 
19.27B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 102.07 
20-SMA 100.09 
50-SMA 99.64 
52-W High 124.49 
52-W Low 29.17 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.95/-6.87
Enterprise Value
19.41B
Balance Sheet
Book Value Per Share
8.23
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DAWNDay One Biopharmaceuticals21.21+8.44+66.09%-- 
After Hours 21.18 -- --
IOVAIovance Biotherapeutics5.135+0.54+11.75%-- 
After Hours 5.08 -- --
EDSAEdesa Biotech6.53+2.92+80.89%-- 
After Hours 6.95 -- --
QNCXQuince Therapeutics0.1023-0.0025-2.39%-- 
After Hours 0.1024 +0.0001 +0.10%
IBRXImmunityBio8.65-0.3001-3.35%-- 
After Hours 8.62 -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.